Search results
Results from the WOW.Com Content Network
Beta blockers have been deemed effective options for the prevention of migraines. In particular, metoprolol, timolol and propranolol have the most strength of efficacy. [9] The timeframe to effectiveness in generally within 3 months. [9] Patients with cardiovascular risk factors should avoid the use of beta blockers for migraine prevention. [9]
CRD carries out systematic reviews and meta-analyses of healthcare interventions, and disseminates the results of research to decision-makers in the NHS. CRD produces three databases: Database of Abstracts of Reviews of Effects (DARE) NHS Economic Evaluation Database (NHS EED) Health Technology Assessment Database (HTA Database)
A 2006 review article by S. Modi and D. Lowder offers some general guidelines on when a physician should consider prescribing drugs for migraine prevention: Following appropriate management of acute migraine, patients should be evaluated for initiation of preventive therapy.
Andrasik, F. "Behavioral Treatment Approaches to Chronic Headache." Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society Of Clinical Neurophysiology 24 Suppl 2 (2003): S80-5. Buchholz, David. Heal Your Headache: The 1-2-3 Program for Taking Charge of Your Headaches. New York: Workman, 2002.
Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...
Migraine (UK: / ˈ m iː ɡ r eɪ n /, US: / ˈ m aɪ-/) [1] [2] is a genetically-influenced complex neurological disorder characterized by episodes of moderate-to-severe headache, most often unilateral and generally associated with nausea and light and sound sensitivity.
Predictors of the relapse, and that could influence treatment strategies, are considered the type of primary headache, from which MOH has evolved, and the type of drug abused (analgesics, and mostly combination of analgesics, but also drugs containing barbiturates or tranquillisers cause significantly higher relapse rates), while gender, age ...
Triptans are a mid-line treatment suitable for many migraineurs with typical attacks. They may not work for atypical or unusually severe migraine attacks, transformed migraine, or status migrainosus (continuous migraine). Triptans are highly effective, reducing the symptoms or aborting the attack within 30 to 90 minutes in 70–80% of patients. [6]